NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: Particular relevance to triple negative subgroup

Breast Cancer Research and Treatment

Volumn 134, Issue 2, 2012, Pages 881-888

  Retsky, Michael ^a,b   Rogers, Rick ^a   Demicheli, Romano ^c   Hrushesky, William J M ^d   Gukas, Isaac ^e   Vaidya, Jayant S ^f   Baum, Michael ^b   Forget, Patrice ^g   De kock, Marc ^g   Pachmann, Katharina ^h  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d Oncology Analytics Inc   (United States)

^e JAMES PAGET UNIVERSITY HOSPITAL   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^h FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Analgesia; Computer simulation; Early relapse; Inflammation; Ketorolac; NSAID; Triple negative breast cancer

Indexed keywords

KETOROLAC;

ADULT; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EARLY CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT CANCER; RISK ASSESSMENT; RISK REDUCTION; TRIPLE NEGATIVE BREAST CANCER; TUMOR SEEDING;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; COMPUTER SIMULATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KETOROLAC; MODELS, BIOLOGICAL; NEOPLASM RECURRENCE, LOCAL; PERIOPERATIVE PERIOD; PROPORTIONAL HAZARDS MODELS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES;

EID: 84868093750     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2094-5     Document Type: Article

References (29)

1. Retsky M, Demicheli R, Hrushesky W, Baum M, Gukas I (2010) Surgery triggers outgrowth of latent distant disease in breast cancer: an inconvenient truth? Cancers 2:305-337. http://www.mdpi.com/2072-6694/2/2/305/
2. Ariel I (1994) A historical review of breast cancer treatment. In: Johnson H, Wise L (eds) Breast cancer: controversies in management. Futura, Armonk, NY
3. Forget P, Vandenhende J, Berliere M, Machiels JP, Nussbaum B, Legrand C, De Kock M (2010) Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis. Anesth Analg 110(6):1630-1635. http://www.ncbi.nlm.nih.gov/pubmed/20435950
4. Gottschalk A, Sharma S, Ford J, Durieux ME, Tiouririne M (2010) Review article: the role of the perioperative period in recurrence after cancer surgery. Anesth Analg 110(6):1636-1643
5. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet, 0099-5355 357:9255
6. Keibel A, Singh V, Sharma MC (2009) Inflammation, microenvironment, and the immune system in cancer progression. Curr Pharm Des 15(17):1949-1955 Review
7. Pascual M, Alonso S, Parés D, Courtier R, Gil MJ, Grande L, Pera M (2011) Randomized clinical trial comparing inflammatory and angiogenic response after open versus laparoscopic curative resection for colonic cancer. Br J Surg 98(1):50-59
8. Demaria S, Pikarsky E, Karin M, Coussens LM, Chen YC, El-Omar EM, Trinchieri G, Dubinett SM, Mao JT, Szabo E, Krieg A, Weiner GJ, Fox BA, Coukos G, Wang E, Abraham RT, Carbone M, Lotze MT (2010) Cancer and inflammation: promise for biologic therapy. J Immunother 33(4):335-351 Review
9. Jones FS, Rous P (1914) On the cause of the localization of secondary tumors at points of injury. J Exp Med 20(4):404-412
10. Der Hagopian RP, Sugarbaker EV, Ketcham A (1978) Inflammatory oncotaxis. JAMA 240(4):374-375
11. El Saghir NS, Elhajj II, Geara FB, Hourani MH (2005) Trauma-associated growth of suspected dormant micrometastasis. BMC Cancer 5:94
12. Walter ND, Rice PL, Redente EF, Kauvar EF, Lemond L, Aly T, Wanebo K, Chan ED (2011) Wound healing after trauma may predispose to lung cancer metastasis: review of potential mechanisms. Am J Respir Cell Mol Biol 44(5):591-596
13. Martins-Green M, Boudreau N, Bissell MJ (1994) Inflammation is responsible for the development of wound-induced tumors in chickens infected with Rous sarcoma virus. Cancer Res 54(16):4334-4341
14. Krebs MG, Hou JM, Ward TH, Blackhall FH, Dive C (2010) Circulating tumour cells: their utility in cancer management and predicting outcomes. Ther Adv Med Oncol 2(6):351-365
15. Zhe X, Cher ML, Bonfil RD (2011) Circulating tumor cells: finding the needle in the haystack. Am J Can Res 1(6):740-751
16. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other tissues. Nature 407:249-257
17. Butler JM, Kobayashi H, Rafii S (2010) Instructive role of the vascular niche in promoting tumor growth and tissue repair by angiocrine factors. Nat Rev Cancer 10:138-146
18. Favaro E, Amadori A, Indraccolo S (2008) Cellular interaction in the vascular niche: implications in the regulation of tumor dormancy. APMIS 116:648-659
19. Kavanagh DP, Kalia N (2011) Hematopoietic stem cell homing to injured tissues. Stem Cell Rev 7:672-682
20. Laurent J, Touvrey C, Botta F, Kuonen F, Ruegg C (2011) Emerging paradigms and questions on pro-angiogenic bone marrow-derived myelomonocytic cells. Int J Dev Biol 55(4-5):527-534
21. Takemoto Y, Li TS, Kubo M, Ohshima M, Ueda K, Harada E, Enoki T, Okamoto M, Mizukami Y, Murata T, Hamano K (2011) Operative injury accelerates tumor growth by inducing mobilization and recruitment of bone marrow-derived stem cells. Surgery 149(6):792-800
22. Bortsov AV, Millikan RC, Belfer I, Boortz-Marx RL, Arora H, McLean SA (2012) μ-Opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer. Anesthesiology 116(4):896-902
23. Pakneshan P, Birsner AE, Adini I, Becker CM, D'Amato RJ (2008) Differential suppression of vascular permeability and corneal angiogenesis by nonsteroidal anti-inflammatory drugs. Invest Ophthalmol Vis Sci 49(9):3909-3913
24. Burke JP, Pestotnik SL, Classen DC, Lloyd JF (1996) Evaluation of the financial impact of ketorolac tromethamine therapy in hospitalized patients. Clin Ther 18(1):197-211
25. Pachmann K (2011) Tumor cell seeding during surgery-possible contribution to metastasis formations. Cancers 3:2540-2553
26. Daskalakis M, Mavroudis D, Sanidas E, Apostolaki S, Askoxylakis I, de Bree E, Georgoulias V, Melissas J (2011) Assessment of the effect of surgery on the kinetics of circulating tumour cells in patients with operable breast cancer based on cytokeratin-19 mRNA detection. Eur J Surg Oncol 37(5):404-410
27. GrØgaard HK, Solheim S, Landsverk KS, Seljeflot I, Hoffmann P, Arnesen H, Ilebekk A (2011) Circulating CD34+ progenitor cells and growth factors in patients treated with PCI for acute myocardial infarction or stable angina pectoris. Scand J Clin Lab Invest 71:322-329
28. Rothwell PM, Price JF, Fowkes FG, Zanchetti A, Roncaglioni MC, Tognoni G, Lee R, Belch JF, Wilson M, Mehta Z, Meade TW (2012) Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 379(9826):1602-1612
29. Wallace TA, Martin DN, Ambs S (2011) Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale. Carcinogenesis 32(8):1107-1121